N-(2-(3,5-Dichlorophenyl)propan-2-yl)acetamide, 95%, 1g

7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 5g

3-(4-fluorophenyl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 250mg

1,3-Bis(4-hydroxybutyl)tetramethyldisiloxane, 10g

3-CYANO-2-METHYLBENZOIC ACID, 95%, 5g

4-isopropyl-2-piperazin-1-yl-1,3-benzothiazole dihydrochloride, 95.0%, 250mg

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 500mg

5-Aminopyrimidine-4,6-diol, 95.0%, 5g

Methyl 3-(2-bromoacetyl)benzoate, 95.0%, 5g

(2e)-3-(3-Fluorophenyl)prop-2-enal, 98+%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((diphenyl(p-tolyl)methyl)thio)propanoic acid, 98%, 500mg

(Trimethylsilyl)methanol, 98%, 1g

Boc-L-tert-Leucine, PEPTIPURE®, min. 98.5%, for biochemistry, 5 g, glass packaging